2020 - Nanbiosis

Looking for volunteers to validate an online learning of minimally invasive surgery (MIS) platform in the framework of EASIER project

The EASIER Project “Technology-enhanced learning of surgical and interventional technical and non-technical skills”, co-founded by the Erasmus + Program of the UE, introduces an innovative paradigm for online learning of minimally invasive surgery (MIS).

EASIER introduces an innovative paradigm for online learning of minimally invasive surgery (MIS) and interventional skills. CCMIJU, partner of NANBIOSIS, is part on the poroject and provides the tools to create pedagogically curated learning courses where students can train both their technical and nontechnical skills. The platform will provide seamless integration of third-party assets (box trainers, virtual reality simulators) that can be used to program simulator tasks as part of specific courses. Course assessment is broken down by the different technical and nontechnical skills, providing a comprehensive record of the resident’s progress to mastery.

NANBIOSIS units at CCMIJU are involved in the project, especially NANBIOSIS U21. Experimental operating rooms, led by Dr. Francisco M. Sánchez Margallo

For more information on project EASIER please visit easier-project.eu, download our cartel or flyer.

Once you complete registration, you are welcome to join us at our kick-off webinar on the 17th December 2020 from 16:00-16:45 CET, where we will present:

The EASIER project goals and mission
The EASIER platform
The validation trials

All volunteers completing the validation will gain exclusive early information before public release and a 1-year free subscription to the EASIER platform.

Enrolment: here

• Read More

NANBIOSIS at the I3A I Conference – IX Conference of Young Researchers

On December 11 the I I3A Conference will take place (online). This Conference is a meeting whose main focus will be the Young Researchers Conference, which is now in its IX edition, and in which there will be scientific conferences that will complete the program. A day dedicated to highlighting the research work in I3A institute of University of Zaragoza.

The BSiCoS group from I3A and CIBER-BBN, coordinator of NANBIOSIS U27 High Performance Computing will be at the I3A Conference, where participatien in the Young Researchers Meeting:

– Pablo Armañac: The capacity of the baroreflex as an identification index of ICU patients prepared for weaning

– Cristina Pérez: From the stress test to the prediction of sudden cardiac death using non-invasive markers

– Saúl Palacios: Periodic dynamics of repolarization as a predictor of sudden death in patients with chronic heart failure

Date: Friday, December 11
Time: 9 am – 6 pm
Online: Via YouTube

The scheduled agenda for the meeting:

9.00 – 9.15 Inauguration (Councilor for Science, Research and the Knowledge Society, Maru Díaz; acting vice-rector for Scientific Policy, Blanca Ros; director of I3A, Pablo Laguna

9.15 – 9.30 “I3A Distinction”

9.30-10.30 Opening conference by Manuel González Bedia “Overview of Spanish scientific policy”

10.30-11.30 Youth presentations (2 presentations)

11.00-12.00 Poster session

12.00-13.00 Youth presentations (4 presentations)

13.00-14.00 Lunch

14.30-15.30 Lecture by Juan Domingo Tardós “How to transfer the software resulting from your research?”

15.30-16.30 Youth presentations (4 presentations)

16.30-17.30 Closing conference by Elías Cueto “Artificial scientists: teaching robots to do science”.

17.30-18.00 Delivery of awards, scholarship diplomas and bridge contracts, and “Distincion I3A”:

– Awards for the best presentations by young researchers (one per division)

– Delivery diploma of recognition of Bridge Contracts

– Delivery diploma of recognition of TFM Scholarships

• Read More

NANBIOSIS participation in the Technology and business Forum “Technological challenges derived from COVID-19”

The pandemic has led companies and researchers to reorient their plans and projects to meet the demands of society.

Different examples of these new challenges will be seen at the next Technology and Business Forum on Thursday, December 10, covering from new tissues, better masks, diagnostic tests, epidemiological models and clinical equipment … All this, from an analysis both from the perspective industrial and research.

The Technological and Business Forum is organized by the Aragón Engineering Research Institute (I3A), the SAMCA Chair of Technological Development, CEOE-Aragón and the Zaragoza Chamber. On this occasion, it will be held online and it will be an opportunity to talk about technologies and COVID-19, to consider the future after this pandemic, given the impact it has had on society and the economy.

At 12:00 the session on “Contributions from research to different COVID challenges· is scheduled, in which, M. Pilar Lobera. researcher at NANBIOSIS U9 Synthesis of Nanoparticles Unit (from CIBER-BBN and- Institute of Nanoscience and Materials of Aragon -INMA- talks on “Challenges for respiratory protection: types of membranes“·
Moderator: Pablo Laguna, Scientific Director of NANBIOSIS U27 High Performance Computing and Director of the SAMCA Chair of Technological Development and I3A

• Read More

2020 Rei Jaume I Awards ceremony – Laura Lechuga NANBIOSIS U4-

This monday 30 of october has taken place the traditional ceremony of Rei Jaume I Awards in Valencia, granted to six professionals in research, science and economics.

At the ceremony, the awards have been given to the winners of the six categories: Rei Jaume I Basic Research Prize 2020 to Fco. José García Vidal; Rei Jaume I Economy Prize 2020 to Diego Puga; Rei Jaume I Medical Research Prize 2020 to Miguel Beato del Rosal; Rei Jaume I Environmental Protection Award 2020 to Fernando T. Maestre; Rei Jaume I New Technologies Award 2020 to Laura Lechuga and Rei Jaume I Entrepreneur Award 2020 to Verónica Pascual.

Queen Letizia has led the event apologizing for the absence of King Felipe VI for being in quarantine, and had estated that the awards constitute “the example of how research, science, technology and entrepreneurship are the way that gives us as a society the tools to face challenges such as those that the pandemic has put on the table”. After, the Queen pointed out that “the talent, effort and generosity” of the winners of the Rei Jaime I Awards, one of the best endowed in Spain with 100,000 euros each discipline , show the ability to project a “modern, supportive and strong” Spain.Queen Letizia has emphasizes at the Rei Jaume I Awards that research is “essential” to face the pandemic.

The winners defend that the coronavirus has reaffirmed the importance of science and that the investment in science must be accompanied by a change in the model.

Laura Lechuga (New Technologies 2020 award), has called for a pact for science to provide stability because science requires long-term financing and structures, as well as decent salaries that prevent the brain drain that is formed with money public. “It is a millionaire loss,” she pointed out.

Prof. Laura M. Lechuga Gomez, full professor of the Spanish National Research Council (CSIC), head of the Nanobiosensors and Bioanalytical Applications group at the ICN2 and a member of the Networking Biomedical Research Centre (CIBER-BBN), received the New Technologies Award for her career in the field of photonic and phononic nanobiosensors. Prof. Lechuga is recently working on a EU funded project (CoNVaT) aiming to apply these technologies to develop a fast, portable and cheap device for the diagnostic of COVID-19.

Prof. Laura M. Lechuga has been recently awarded with the two most prominent scientific Prizes in Spain Rei Jaume I and the Spanish National Research Award.

The research group led by Laura Lechuga on Nanobiosensors and Bioanalytical Applications (NAnoB2A) from CIBER-BBN and ICN2-CSIC, coordinators of unit 4 ot NANBIOSIS ICTS have been folloing the Rei Jaume I awards ceremony in streaming, from the ICN2-CSIC, very proud of Laura Lechuga!

• Read More

Nb4D group- NANBIOSIS U2 receives the acreditation TECNICO, in the on line event organizes by ACCIO

Las November 27 was held the ACCIO ceremony (on line this year due to the Covid Pandemic restrictions) of disclosure of new TECNIO accreditations.

Aurea Rodriguez, Director of Business Innovation at ACCIO has welcomed the attendees to the event. Later, the TECNIO program Coordinator, Marta Peidro, presented the background and rationale for this accreditation for excellence groups in technology transfer in Catalonia. This year there have been five new groups from among all Catalan universities and research organizations, which have obtained the TECNIO accreditation for the first time, making a total of fifty-four groups accredited in 2020.

The event continued with the presentation of the five new accredited groups, starting with the IQAC-CSIC – CIBER-BBN Nb4D group, coordinator of NANBIOSIS unit 2 Custom Antibody Service (CAbS) that investigates improvements to current clinical diagnostic methods.

After the presentations of the five new groups, the tools and benefits that ACCIO offers to TECNIO groups were explained and the event ended with a round of questions from the attendees, such as what will be the future financing strategy of ACCIO for TECNIO groups or how has it been the response to the recent call for INNOTEC grants

As expressed by Prof M. Pilar Marco: “This seal recognizes us as a tech-transfer agent with distinguishing technological capabilities and increases our visibility in front of the business world.”

ACCIÓ is the agency set up by the Catalan Government to make Catalan enterprise more competitive throughout the world. Its key aims are to drive innovation, internationalisation and attract inward investment. ACCIÓ is enterprise-centred, working on the needs of each individual business and to work hand in hand to look for opportunities and achieve that all important competitive edge. At ACCIÓ we believe this edge can come about with work on three vital areas of competitive dynamics: innovation, internationalisatio, attraction of investment. ACCIÓ is a proactive agency, with a simple, clear and efficient modus operandi, above all dedicated to working in close quarters with enterprise. ACCIÓ is based in Barcelona with an international network of a further 35 Business Promotion Centres covering some 80 markets worldwide. It provides advice and practical help for businesses with a vocation to expand worldwide. It focuses on attracting inward investment into Catalonia and also works on synergies between R+D+i areas and business.

• Read More

U20-S015. Cytotoxicity: proliferation, LDH, apoptosis and ROS

• Read More

U20-S014. Hemocompatibility: hemolysis, platelet aggregation, plasma coagulation times and complement activation

• Read More

U20-S013. Detection of microbial (bacterial and mycoplasma) contaminationpre

• Read More

Two new equipment items at the U6 of Nanbiosis with cofinancing from FEDER funds

The U6 of NANBIOSIS (Biomaterial Processing and Nanostructuring Unit) has expanded its capabilities with 2 new equipment items for the characterization unit. Both equipment items will allow the characterization of some physico-chemical properties of different nanomaterials.

The Zetasizer ULTRA is used to measure the particle size of dispersed systems from sub-nanometer to several micrometers in diameter, using the technique of Dynamic Light Scattering (DLS). Zetasizer systems are also used to analyze particle mobility and charge (Zeta potential) using the technique of Electrophoretic Light Scattering (ELS), and the molecular weight of particles in solution using Static Light Scattering (SLS).

The Green laser module for the NanoSight NS300 equipment. The NS300 allows analysis of the size distribution and concentration of all types of nanoparticles from 0.01 – 1 µm in diameter. This new laser module will allow NTA to measure a range of fluorescent particles, avoiding interferences during the measurements due to sample (auto)fluorescence and absorption. This is done by detecting the fluorescence signal, which is emitted naturally by particles or as a result of fluorescence labeling or tagging

This equipment have been confinanced by the European Regional Development Fund (ERDF) through the Plurirregional Operational Program of Spain (POPE)2014-2020

• Read More

The Nanomedicine Revolution

Yesterday, November, 25 took place, within the the program of the Ateneo of the EINA (School of Engineering and Architecture of Aragón), the online conference on “The Revolution of Nanomedicine” by Ramón Martínez Máñez.

The Conference chair, Jesús Martínez de la Fuente, Principal Investigator of the BIONANOSURF group of CIBER-BBN and the Institute of Nanoscience and Materials of Aragón, introduced the guest, Ramón Martínez Máñez, Scientific Director of CIBER-BBN, highlighting “his creativity in the use of his systems and how he combines them with different diagnostic release systems, combining organic chemistry, surface chemistry, applications in biotechnology and giving way to translation and transfer, his works are very unique“

Ramón Martínez Máñez, Scientific Director NANBIOSIS unit 26 NMR: Biomedical Applications II, gave a very instructive talke about what is nanotechnology and how nanotechnology revolution has reached the medicine, with current examples of the application of nanomedicines, as well as in the medicine of the future.

After it, a very interesting debate took place in which different issues were discussed, especially in relation to nanomedicine applied to therapy, such as the barriers to generalize the use of nanoparticles in therapy, the current state of implantation of nanoformulated drugs in the market and the advancement of the use of some nanoparticles as polymers or liposomes compared to inorganic nanoparticles, the degree of development of nanoparticles under GLP certification or why cancer is the main target of nanomedicine with a great difference over other pathologies. The audience asked questions that led to the discussion of some more controversial points such as whether it is true that “Big Pharma” does not like nanoparticles, why there is a regulatory vacuum regarding their use and how to solve these problems.

Regarding the diagnosis applications, Ramón Martínez commented that “nanotechnology already has its way open, both in the development of nanoparticles and systems to amplify the signal, based on nanophotonics, resonant rings or other technologies at the nanometric level. The pandemic has highlighted the importance of having rapid detection systems for bio parameters, pathogens, bacteria … We have a lot of knowledge acquired in recent years in these systems and they are currently being developed in a more or less short time, we are truly close to revolutionizing the field of detection“.

Finally, in realtion with the nanomedicine of the future, the questions raised in the debate revolved mainly around nanobots and their state of development or the problems that are emerging in it or the possibility of uniting nanomedicine with artificial intelligence and possible applications.

The Ateneo is an activity of the EINA in collaboration with the Aragón Engineering Research Institute and SAMCA Chair of Technological Development of Aragon, both directed by Pablo Laguna, Scientific Director of Nanbiosis U27 High Performance Computing. Pablo Laguna closed the event thanking Ramón Martínez Máñez and Jesús Martínez de la Fuente for their participation and highlighting the high number of attendees at the conference.

The conference can be followed in Spanish in EINA youtoube channel: https://www.youtube.com/watch?v=Y_Fh1O1VuNU

Anouncing this Conference in the Ateneo EINA, Ramón Martínez Máñez was yesterday interviewed by Aragon Radio. In this case, the interview had the focuss in the “Nanomedicine against COVID” . The podcast can be listen in Spanish here: https://www.cartv.es/aragonradio/podcast/emision/nanomedicina-frente-a-la-covid

• Read More

Nanbiosis

You are here : Home / 2020 (Page 2)

The U6 of NANBIOSIS (Biomaterial Processing and Nanostructuring Unit) has expanded its capabilities with 2 new equipment items for the characterization unit. Both equipment items will allow the characterization of some physico-chemical properties of different nanomaterials.